Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: A possible predictive marker of ocular attack

Modern Rheumatology

Volumn 18, Issue 4, 2008, Pages 354-358

  Nanke, Yuki ^a   Kotake, Shigeru ^a   Goto, Mari ^b   Ujihara, Hiroshi ^b   Matsubara, Masao ^b   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Behcet's disease; Ocular attack; Regulatory T

Indexed keywords

COLCHICINE DERIVATIVE; CYCLOSPORIN; MIZORIBINE; PREDNISOLONE;

ADULT; AGED; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN DISEASE; CONTROLLED STUDY; EYE DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; OUTPATIENT DEPARTMENT; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADULT; AGED; BEHCET SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; UVEITIS;

EID: 49149117727     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-008-0064-x     Document Type: Article

References (18)

1. Sakane T. Behcet's disease. N Eng J Med. 1999;341:1284-91.
2. Nanke Y, Kotake S, Tateishi M, Yamanaka H, Kamatani N. Synovial histology in three Behcet's disease patients with orthopedic surgery. Clin Exp Rheumatol. 2002;20:35-44.
3. Nanke Y, Kotake S, Ogasawara K et al. Raised plasma adrenomedullin level in Behcet's disease patients. Mod Rheumatol. 2003;13:139-42.
4. Sakaguchi S, Sakaguchi N, Shimizu J. Immunological tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18-32.
5. Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes J. Clin Investig. 2002;109:131-40.
6. Amelsfort J, Jacvobs K, Bijlsma J, Lafeber F, Taams L. CD4+ CD25+ regulatory T cells in rheumatoid arthritis. Difference in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004;50:2775-85.
7. Cao D. Isolation and functional characterization of regulatory CD25brightCD4 T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215-23.
8. Crispin JC, Martinez A, Varela JA. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2003;21:273-6.
9. Gottenberg JE, Lavie F, Abbed K et al. CD4+ CD25+ high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun. 2005;24:235-42.
10. International Study Group for Behcet's Disease: Criteria for diagnosis of Behcet's disease. Lancet. 1999;335:1078-80.
11. Behcet's Disease Research Committee of Japan. Behcet's disease: A guide to diagnosis of Behcet's disease. Jpn J Ophthalmol. 1974;18:291-4.
12. Jiao Z, Wang W, Jia R et al. Accumulation of FoxP3-expressing CD4(+) CD25(+) T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol. 2007;36:428-33.
13. Grajewski R, Silver P, Agarwal RK et al. Endogenous IRBP can be dispensable for generation of natural CD4+ CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. JEM. 2006;203:851-6.
14. Ehrenstein MR, Evans JG, Singh A et al. Compromised function of regulatory T cells in Rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med. 2004;200:277-85.
15. Sarin A, Conan-Cibotti M, Henkart P. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol. 1995;155:3716-8.
16. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Fox P3. Science. 2003;299:1057-61.
17. Allan SE, Crome SQ, Crellin NK et al. Activation-induced FoxP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol. 2007;19:345-54.
18. Hamzaoui K, Hamzaoui A, Houman H. CD4+ CD25+regulatory T cells in patients with Behcet's disease. Clin Exp Rheumatol. 2006;24:S71-8.